Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Diagnostic delay in malignant melanoma].

R S Faye1, P Helsing, F Langmark

  • 1Hudavdelingen Rikshospitalet, Oslo.

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|June 2, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cyclic photodynamic therapy delays first onset of actinic keratoses in renal transplant recipients: a 5-year randomized controlled trial with 12-month follow-up.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia.

Genetics in medicine : official journal of the American College of Medical Genetics·2021
Same author

MC1R gene variants and non-melanoma skin cancer: a pooled-analysis from the M-SKIP project.

British journal of cancer·2015
Same author

Increased stomach cancer risk following radiotherapy for testicular cancer.

British journal of cancer·2014
Same author

Pancreatic cancer risk after treatment of Hodgkin lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same author

Intensified fractional CO2 laser-assisted photodynamic therapy vs. laser alone for organ transplant recipients with multiple actinic keratoses and wart-like lesions: a randomized half-side comparative trial on dorsal hands.

The British journal of dermatology·2013
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Correction: Management of acute epistaxis.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

A woman in her 70s with chest pain and elevated troponin T levels.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

More systematic follow-up after childbirth.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
See all related articles

Malignant melanoma diagnosis is often delayed by patients, especially younger men, who underestimate concerning skin changes. Public health campaigns should encourage prompt medical consultation for suspicious moles.

Area of Science:

  • Dermatology
  • Oncology
  • Public Health

Context:

  • Malignant melanoma is a rapidly increasing cancer type.
  • Early diagnosis and treatment are crucial for a favorable prognosis.

Purpose:

  • Investigate diagnostic delays in malignant melanoma.
  • Assess patient knowledge regarding malignant melanoma.

Summary:

  • Median patient delay in seeking medical advice for suspicious moles was eight weeks, with younger men exhibiting the longest delays.
  • Median professional delay from initial consultation to diagnosis was one week.
  • Many patients (60%) delayed seeking care due to underestimating lesion significance; 65% initiated consultations themselves.

Impact:

Related Experiment Videos

  • Public health campaigns should target younger men, emphasizing self-examination and immediate consultation for suspicious lesions.
  • Improving patient awareness and reducing diagnostic delays can enhance malignant melanoma outcomes.